60 Minutes highlights how scientists are using ReFRAME, an extensive library of over 14,000 small-molecule drugs shown to be appropriate for direct use in humans, in the fight against the novel coronavirus (COVID-19). Calibr—the drug development division of Scripps Research—compiled ReFRAME with support from the Bill & Melinda Gates Foundation.
Ещё видео!